ClinVar Miner

Submissions for variant NM_006766.5(KAT6A):c.4968_4982dup (p.Gln1657_Pro1661dup)

dbSNP: rs750049486
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002534532 SCV000846648 uncertain significance Inborn genetic diseases 2016-05-24 criteria provided, single submitter clinical testing The c.4968_4982dup15 variant (also known as p.Q1657_p1661dup), located in coding exon 16 of the KAT6A gene, results from an in-frame duplication of 15 nucleotides between nucleotide positions 4968 and 4982. This results in the duplication of 5 extra residues (QQPQP) between codons 1657 and 1661. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6302 samples (12604 alleles) with coverage at this position. These amino acid positions are not well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GeneDx RCV001683636 SCV001900152 benign not provided 2020-10-01 criteria provided, single submitter clinical testing
Invitae RCV001683636 SCV002454221 likely benign not provided 2024-01-25 criteria provided, single submitter clinical testing
Ambry Genetics RCV002534532 SCV003715090 likely benign Inborn genetic diseases 2021-09-02 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CeGaT Center for Human Genetics Tuebingen RCV001683636 SCV004157538 benign not provided 2024-03-01 criteria provided, single submitter clinical testing KAT6A: BS1, BS2
PreventionGenetics, part of Exact Sciences RCV003928189 SCV004741378 likely benign KAT6A-related disorder 2021-05-11 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.